SI1771450T1 - Spojine in postopki za inhibiranje mitotične progresije z inhibicijo kinaze Aurora - Google Patents

Spojine in postopki za inhibiranje mitotične progresije z inhibicijo kinaze Aurora

Info

Publication number
SI1771450T1
SI1771450T1 SI200530184T SI200530184T SI1771450T1 SI 1771450 T1 SI1771450 T1 SI 1771450T1 SI 200530184 T SI200530184 T SI 200530184T SI 200530184 T SI200530184 T SI 200530184T SI 1771450 T1 SI1771450 T1 SI 1771450T1
Authority
SI
Slovenia
Prior art keywords
inhibition
compounds
methods
aurora kinase
mitotic progression
Prior art date
Application number
SI200530184T
Other languages
English (en)
Inventor
Christopher F Claiborne
Lloyd J Payne
Richard J Boyce
Todd B Sells
Stephen G Stroud
Stuart Travers
Tricia J Vos
Gabriel S Weatherhead
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Priority claimed from EP05779921A external-priority patent/EP1771450B9/en
Publication of SI1771450T1 publication Critical patent/SI1771450T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200530184T 2004-05-14 2005-05-12 Spojine in postopki za inhibiranje mitotične progresije z inhibicijo kinaze Aurora SI1771450T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US57165304P 2004-05-14 2004-05-14
US61722104P 2004-10-08 2004-10-08
EP05779921A EP1771450B9 (en) 2004-05-14 2005-05-12 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
PCT/US2005/016445 WO2005111039A2 (en) 2004-05-14 2005-05-12 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase

Publications (1)

Publication Number Publication Date
SI1771450T1 true SI1771450T1 (sl) 2008-06-30

Family

ID=39126531

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200530184T SI1771450T1 (sl) 2004-05-14 2005-05-12 Spojine in postopki za inhibiranje mitotične progresije z inhibicijo kinaze Aurora

Country Status (4)

Country Link
EP (1) EP1905773B1 (sl)
DK (1) DK1905773T3 (sl)
PL (1) PL1905773T3 (sl)
SI (1) SI1771450T1 (sl)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4318854A (en) 1979-02-07 1982-03-09 Hoffmann-La Roche Inc. Intermediates in the production of 2-benzazepines
US4547581A (en) 1979-02-07 1985-10-15 Hoffmann-La Roche Inc. Pyrimido-2-benzazepines and intermediates in their preparation
JP2001507349A (ja) * 1996-12-23 2001-06-05 セルテック セラピューティックス リミテッド 縮合多環式2−アミノピリミジン誘導体、それらの製造およびたんぱく質チロシンキナーゼ抑制因子としてのそれらの使用
GB9914258D0 (en) 1999-06-18 1999-08-18 Celltech Therapeutics Ltd Chemical compounds
KR100947185B1 (ko) * 2000-12-21 2010-03-15 버텍스 파마슈티칼스 인코포레이티드 단백질 키나제 억제제로서 유용한 피라졸 화합물 및 이를 포함하는 조성물

Also Published As

Publication number Publication date
EP1905773B1 (en) 2012-07-18
EP1905773A2 (en) 2008-04-02
DK1905773T3 (da) 2012-10-15
PL1905773T3 (pl) 2012-12-31
EP1905773A3 (en) 2008-04-09

Similar Documents

Publication Publication Date Title
HK1205102A1 (en) Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
ME00716B (me) Jedinjenja i postupci za inhibiciju mitotičke progresije inhibiranjem aurora kinaze
EP1957078A4 (en) PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING CANCER BY INHIBITING AURORA KINASE
GB2432165B (en) Method of inhibiting hydrate formation
IL189933A0 (en) Rna antagonist compounds for the inhibition of apo-b100 expression
EP2121637A4 (en) ANTHRANILAMIDE INHIBITORS OF AURORA KINASE
ZA200804253B (en) Method of inhibiting FLT3 kinase
HK1134672A1 (en) Compounds for inhibiting mitotic progression
ZA200704106B (en) Inhibitors of c-fms kinase
EP1954290A4 (en) AS KINASE-HEMMER USES TRICYCLIC COMPOUNDS
IL172375A0 (en) Chinazoline derivatives as aurora kinase inhibitors
EP1778693A4 (en) AS KINASEINHIBITORS USEFUL COMPOUNDS OF TRICYCLIC HETEROARYL
HK1144392A1 (en) Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
GB0608823D0 (en) Inhibitors of P13 kinase
ZA200700826B (en) Thienopyrimidines useful as Aurora kinase inhibitors
ZA200809874B (en) Method of inhibiting c kit kinase
IL182735A0 (en) Inhibitors of c-fms kinase
EP1906967A4 (en) ABL Kinase Inhibition
SI1905773T1 (sl) Spojine in postopki za inhibiranje mitotične progresije z inhibiranjem aurora kinaze
EP1771203A4 (en) INHIBITION OF NF-KB
EP1605893A4 (en) TRANS-MEMBRANE ANTIBODY-INDUCED APOPTOSIS INHIBITION
SI1771450T1 (sl) Spojine in postopki za inhibiranje mitotične progresije z inhibicijo kinaze Aurora
EP1776140A4 (en) METHOD FOR INHIBITING VIRAL REPLICATION
GB0410299D0 (en) Inhibition of biofilm formation
GB0621606D0 (en) Inhibitors of p13 kinase